Orgenesis Inc.
ORGS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $145 | $489 | $699 | $959 |
| - Cash | $1 | $5 | $5 | $45 |
| + Debt | $23 | $20 | $12 | $13 |
| Enterprise Value | $167 | $504 | $705 | $927 |
| Revenue | $1 | $36 | $36 | $8 |
| % Growth | -98.5% | 1.5% | 364% | – |
| Gross Profit | -$6 | $16 | $7 | -$23 |
| % Margin | -1,080.2% | 43.3% | 20.7% | -306.4% |
| EBITDA | -$61 | -$8 | -$16 | -$94 |
| % Margin | -11,456.2% | -22.6% | -44.3% | -1,231.1% |
| Net Income | -$55 | -$15 | -$18 | -$96 |
| % Margin | -10,445.5% | -41.3% | -50.9% | -1,252.1% |
| EPS Diluted | -1.91 | -0.59 | -0.74 | -4.46 |
| % Growth | -223.7% | 20.3% | 83.4% | – |
| Operating Cash Flow | -$15 | -$25 | -$27 | -$78 |
| Capital Expenditures | -$2 | -$12 | -$8 | -$2 |
| Free Cash Flow | -$17 | -$37 | -$35 | -$80 |